- SMIMA1081U - Drug Regulatory Affairs in Drug Development
- SMIMA1091U - Quality by Design (QbD) in Pharmaceutical Development
- SMIMA1101U - QA, QC, GXP for Pharmaceutical Production
- SMIMA1161U - Drug Formulation and Delivery
- SMIMB1011U - Discovery and Development of Medicines
- SMIMB1041U - Pharmacology
- SMIMB1051U - Non-clinical Safety and Toxicology
- SMIMB1151U - Clinical Pharmacology and Biostatistics
- SMIMIF115U - Market Access for Pharmaceutical Products – trends and challenges
- SMIMIL014E - Master's project
- SMIMIL02IE - Independet Elective Study
- SMIMIL171U - Biopharmaceuticals Drug Development
- SMIMM1131U - Drug Discovery
- SMIMM1141U - Chemical Process Development and Production of Active Pharmaceutical Ingredients (API)
- SMPMA0014E - Master's project
- SMPMA3101U - Biopharmaceuticals – Quality Development and Documentation
- SMPMA3131U - Medical Devices – Drug/Device Combinations
- SMPMA3141U - Regulatory Affairs in the EU
- SMPMA3151U - Regulatory Strategic Considerations during Global Drug Development
- SMPMA3161U - Quality - Drug Substance and Drug Product
- SMPMA3171U - Non-clinical Documentation
- SMPMA3181U - Clinical Development and Documentation
- SMPMA3191U - Product Life Cycle Activities
- SMPMA3201U - Role and Responsibilities of a Regulatory Affairs Professional
- SMPMA3211U - The Regulatory Affairs Environment in the USA
- SMPMIF091U - The Regulatory Affairs in Japan